Cause of the Most Devastating Pandemics in History Revealed
|
By LabMedica International staff writers Posted on 04 Feb 2014 |

Image: Tooth of one of the plague victims buried in Bavaria (Photo courtesy of McMaster University).
A new study reveals that two of the world's most devastating pandemics, the plague of Justinian and the Black Death, were caused by distinct strains of the same pathogen.
Researchers at McMaster University (Hamilton, ON, Canada), Northern Arizona University (Flagstaff, USA), the University of Sydney (Australia), and other institutions isolated miniscule DNA fragments from the 1,500 year old teeth of two victims of the Justinian plague, who were buried in the Aschheim-Bajuwarenring cemetery (Bavaria, Germany); these are the oldest pathogen genomes obtained to date. Using these short fragments, the researchers reconstructed the genome of the bacterium responsible, and compared it to a database of genomes of more than a hundred contemporary strains.
The results showed that the bacterium was a strain of Yersinia pestis, the same pathogen responsible for the Black Death. But while the strain responsible for the Justinian outbreak was an evolutionary “dead-end” and faded out on its own, the other, likely a descendant of the Black Death strain, lead to another worldwide pandemic spreading from Hong Kong across the globe in the late 1800’s. According to the researchers, these findings suggest a new strain of plague could emerge again in humans in the future. The study was published online on January 28, 2014, in the Lancet Infectious Diseases.
“About 200 rodent species carry the plague and could potentially infect other animals or humans. Scientists need to sharpen their surveillance of plague in rodent populations to try averting future human infections,” said lead author Associate Professor Hendrik Poinar, PhD, director of the McMaster Ancient DNA Center. “If we happen to see a massive die-off of rodents somewhere, then it would become alarming. Plague is something that will continue to happen, but modern-day antibiotics should be able to stop it.”
The Plague of Justinian struck in the sixth century and it is estimated to have killed between 30 and 50 million people—virtually half the world's population—as it spread across Asia, North Africa, The Arabian peninsula, and Europe. The Black Death struck some 800 years later with similar force, killing 50 million Europeans in just four years (1347-1351).
Related Links:
McMaster University
Northern Arizona University
University of Sydney
Researchers at McMaster University (Hamilton, ON, Canada), Northern Arizona University (Flagstaff, USA), the University of Sydney (Australia), and other institutions isolated miniscule DNA fragments from the 1,500 year old teeth of two victims of the Justinian plague, who were buried in the Aschheim-Bajuwarenring cemetery (Bavaria, Germany); these are the oldest pathogen genomes obtained to date. Using these short fragments, the researchers reconstructed the genome of the bacterium responsible, and compared it to a database of genomes of more than a hundred contemporary strains.
The results showed that the bacterium was a strain of Yersinia pestis, the same pathogen responsible for the Black Death. But while the strain responsible for the Justinian outbreak was an evolutionary “dead-end” and faded out on its own, the other, likely a descendant of the Black Death strain, lead to another worldwide pandemic spreading from Hong Kong across the globe in the late 1800’s. According to the researchers, these findings suggest a new strain of plague could emerge again in humans in the future. The study was published online on January 28, 2014, in the Lancet Infectious Diseases.
“About 200 rodent species carry the plague and could potentially infect other animals or humans. Scientists need to sharpen their surveillance of plague in rodent populations to try averting future human infections,” said lead author Associate Professor Hendrik Poinar, PhD, director of the McMaster Ancient DNA Center. “If we happen to see a massive die-off of rodents somewhere, then it would become alarming. Plague is something that will continue to happen, but modern-day antibiotics should be able to stop it.”
The Plague of Justinian struck in the sixth century and it is estimated to have killed between 30 and 50 million people—virtually half the world's population—as it spread across Asia, North Africa, The Arabian peninsula, and Europe. The Black Death struck some 800 years later with similar force, killing 50 million Europeans in just four years (1347-1351).
Related Links:
McMaster University
Northern Arizona University
University of Sydney
Latest Microbiology News
- High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
- Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
- Rapid Sepsis Diagnostic Device to Enable Personalized Critical Care for ICU Patients
- Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
- New Diagnostic Method Confirms Sepsis Infections Earlier
- New Markers Could Predict Risk of Severe Chlamydia Infection
- Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
- CRISPR-Based Saliva Test Detects Tuberculosis Directly from Sputum
- Urine-Based Assay Diagnoses Common Lung Infection in Immunocompromised People
- Saliva Test Detects Implant-Related Microbial Risks
- New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance
- Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis
- Viral Load Tests Can Help Predict Mpox Severity
- Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
- Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
- Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
Channels
Clinical Chemistry
view channel
VOCs Show Promise for Early Multi-Cancer Detection
Early cancer detection is critical to improving survival rates, but most current screening methods focus on individual cancer types and often involve invasive procedures. This makes it difficult to identify... Read more
Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
Kidney disease is typically diagnosed through blood or urine tests, often when patients present with symptoms such as blood in urine, shortness of breath, or weight loss. While these tests are common,... Read moreMolecular Diagnostics
view channel
Fast Low-Cost Alzheimer’s Tests Could Detect Disease in Early and Silent Stages
Early diagnosis remains one of the greatest challenges in combating Alzheimer’s disease, the most common cause of age-related dementia. With symptoms like memory loss and confusion typically appearing... Read more
Further Investigation of FISH-Negative Tests for Renal Cell Carcinoma Improves Diagnostic Accuracy
Accurate diagnosis of renal cell carcinoma (RCC) is critical to determining the right therapy, but standard diagnostic methods can sometimes miss important genetic alterations. Now, researchers have discovered... Read more
First Direct Measurement of Dementia-Linked Proteins to Enable Early Alzheimer’s Detection
The disease process in Alzheimer’s begins long before memory loss or cognitive decline becomes apparent. During this silent phase, misfolded proteins gradually form amyloid fibrils, which accumulate in... Read moreHematology
view channel
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage
Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read moreImmunology
view channel
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
Immunotherapy has revolutionized cancer care by harnessing the immune system to fight tumors, yet predicting who will benefit remains a major challenge. Many patients undergo costly and taxing treatment... Read moreMicrobiology
view channel
High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
Candida bloodstream infections are a growing global health threat, causing an estimated 6 million cases and 3.8 million deaths annually. Hospitals are particularly vulnerable, as weakened patients after... Read morePathology
view channel
3D Genome Mapping Tool to Improve Diagnosis and Treatment of Genetic Diseases
Standard laboratory tests often fail to detect complex DNA rearrangements that underlie many genetic diseases. To bridge this diagnostic gap, researchers have developed a 3D chromosome mapping method that... Read more
New Molecular Analysis Tool to Improve Disease Diagnosis
Accurately distinguishing between similar biomolecules such as proteins is vital for biomedical research and diagnostics, yet existing analytical tools often fail to detect subtle structural or compositional... Read more
Tears Offer Noninvasive Alternative for Diagnosing Neurodegenerative Diseases
Diagnosing and monitoring eye and neurodegenerative diseases often requires invasive procedures to access ocular fluids. Ocular fluids like aqueous humor and vitreous humor contain valuable molecular information... Read moreTechnology
view channel
Portable Biosensor Diagnoses Psychiatric Disorders Using Saliva Samples
Early diagnosis of psychiatric disorders such as depression, schizophrenia, and bipolar disorder remains one of medicine’s most pressing challenges. Current diagnostic methods rely heavily on clinical... Read more
Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement
Sorting different cell types—such as cancerous versus healthy or live versus dead cells—is a critical task in biology and medicine. However, conventional methods often require labeling, chemical exposure,... Read moreIndustry
view channel
Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
QIAGEN (Venlo, Netherlands) has entered into a definitive agreement to fully acquire Parse Biosciences (Seattle, WA, USA), a provider of scalable, instrument-free solutions for single-cell research.... Read more
Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
Puritan Medical Products (Guilford, ME, USA), the world’s most trusted manufacturer of swabs and specimen collection devices, is set to exhibit at AMP2025 in Boston, Massachusetts, from November 11–15.... Read more
Advanced Instruments Merged Under Nova Biomedical Name
Advanced Instruments (Norwood, MA, USA) and Nova Biomedical (Waltham, MA, USA) are now officially doing business under a single, unified brand. This transformation is expected to deliver greater value... Read more








